Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2018-09-14

FDA Approved: ZOLPIDEM TARTRATE — Supplemental Application (Sanofi-Aventis U.S. LLC)

View source ↗

Summary

FDA approved a supplemental application for zolpidem tartrate by Sanofi-Aventis U.S. LLC to update the labeling of the approved insomnia medication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zolpidem Tartrate (zolpidem tartrate)

Snippet

SUPPL AP for ZOLPIDEM TARTRATE (ZOLPIDEM TARTRATE)